Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Doctor Anywhere is a telehealth company .
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.
Halodoc is a health-tech platform that connects patients with doctors, insurance, labs, and pharmacies.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
CorWave is a medical device company developing innovative heart pumps.
Roslin Technologies is a biotechnology company that focuses on developing technologies for the agricultural and animal health sectors.
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Aquafortus is a non-thermal recovery and crystallization technology platform.
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
Kate Farms offers plant-based shakes and formulas for tube-fed adults and children.
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
21st Bio has the potential to replace and improve a wide range of meals and materials with appealing sustainable bio-based alternatives.
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma. The firm invests across 28 different industry categories.
Among tracked funding rounds, Morphic Therapeutic received $276.0M in a Post Ipo Equity round. Novo Holdings's total known invested capital is $15.2B.
Novo Holdings's average investment size is $84.4M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include Doctor Anywhere, Exscientia, Arcellx, Terremoto Biosciences, Minervax. These companies were founded in 2020 or later.